{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-003401","form_type":"8-K","ticker":"RAPH","cik":"0001415397","company_name":"Raphael Pharmaceutical Inc.","filed_at":"2025-01-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.572743+00:00","generated_at":"2026-05-28T01:52:35.907158+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Raphael Pharmaceuticals appoints Ajay Kumar Dhadha as Director and Chairman, replacing Shlomo Pilo","bullets":["Board expanded by one seat; Ajay Kumar Dhadha appointed Director and Chairman effective January 8, 2025.","Dhadha, age 79, is a diamond dealer, founder/CEO of Shanti Gems (1982) Ltd., and Israel Diamond Exchange member.","No arrangement, transaction, or reportable relationship exists between Dhadha and the company under Item 404(a).","Board concluded Dhadha is qualified and independent; standard indemnification agreement to be entered."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-003401","json":"https://secwatch.observer/filing/0001213900-25-003401.json","markdown":"https://secwatch.observer/filing/0001213900-25-003401.md","text":"https://secwatch.observer/filing/0001213900-25-003401.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1415397/000121390025003401/0001213900-25-003401-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1415397/000121390025003401/ea0227340-8k_raphael.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T01:52:35.907158+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0ea5524fa2","claim":"Ajay Kumar Dhadha was appointed as Director and Chairman at Raphael Pharmaceutical Inc..","evidence_excerpt":"The Board also selected Mr. Dhadha to be Chairman of the Board, replacing Mr. Shlomo Pilo in such role.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1415397/000121390025003401/0001213900-25-003401-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director and Chairman"}],"fact_type":"executive_change"},{"claim_id":"eb4876e557","claim":"Shlomo Pilo changed role as Chairman at Raphael Pharmaceutical Inc..","evidence_excerpt":"The Board also selected Mr. Dhadha to be Chairman of the Board, replacing Mr. Shlomo Pilo in such role.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1415397/000121390025003401/0001213900-25-003401-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"replaced"},{"label":"Role","value":"Chairman"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}